Anticoagulation Therapy Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023

Global Anticoagulation Therapy Market: By Drug Type (Warfarin, Heparin, Novel Oral Anticoagulants, Others), By Route of Administration (Oral, Parenteral), By Application (Therapeutic applications, Laboratory Services), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Market Outline: Anticoagulation Therapy Market
Anticoagulation therapy is the procedure carried by using anticoagulants to reduce or prevent the coagulation of blood by enhancing the clotting time. Most commonly used anticoagulants are heparin and warfarin. Anticoagulation therapy is indicated in various cardiac and thrombotic disorders such as myocardial infarction, coronary artery disease, atrial fibrillation, pulmonary embolism, deep vein thrombosis, and restenosis among others. In these conditions, anticoagulation therapy can prevent the formation of clots or inhibit the growth of clots. In addition, anticoagulants are also used in the laboratory testing services such as serum separation, blood transfusion, dialysis, and blood sample analysis among others.

A sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/anticoagulation-therapy-market/#ulp-4H8Z4LpNMLEuOnnx

Market Dynamics: Anticoagulation Therapy Market
Increase in the prevalence of cardiovascular diseases such as coronary artery disease, rise in R&D for the innovation of novel oral anticoagulants, wide range of applications of anticoagulants, and increase in the use of anticoagulants as alternative to antiplatelet drugs are anticipated to boost the anticoagulation therapy market over the forecast period. Moreover, rise in blood transfusions and growing awareness about anti-coagulants therapy among physicians are anticipated to propel the market. However, stringent regulatory policies for product approval, high cost of the treatment, and adverse effects associated with anticoagulants are expected to hinder the growth of anticoagulation therapy market.

Market Scope: Anticoagulation Therapy Market
Anticoagulation therapy market is segmented on the basis of drug type, route of administration, application, distribution channel, and region
Based on the drug type, the market is segmented into the following:
• Warfarin
• Heparin
• Novel Oral Anticoagulants
o Direct Factor Xa Inhibitors
o Direct Thrombin Inhibitors
o Antithrombin Protein Therapeutics
• Others
Based on the route of administration, the market is segmented into the following:
• Oral
• Parenteral
Based on the application, the market is segmented into the following:
• Therapeutic applications
• Laboratory Services
Based on the distribution Channel, the market is segmented into the following:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
Based on region, the market is segmented into the following:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

To view TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/anticoagulation-therapy-market#ulp-c654SbFYO64MsOhu

Market Summary: Anticoagulation Therapy Market
Increase in the prevalence of cardiovascular diseases such as coronary artery disease, atrial fibrillation, and venous thromboembolism are spurred the growth of anticoagulation therapy market. According to International Society on Thrombosis and Haemostasis, Inc. nearly 10 Mn venous thromboembolism cases observed every year around the globe. In addition, product approval and product launchings are the key strategies help to generate the revenue in anticoagulation therapy market. For instance, in November 2012, Janssen Pharmaceuticals received FDA approval for Xarelto, an oral anticoagulant used in the treatment of deep vein thrombosis and pulmonary embolism. Furthermore, promising pipeline products might upsurge the revenue of anticoagulation therapy over the forecast years. For instance, in November 2016, Baxter International Inc. started phase 3 clinical trial for citrate anticoagulant used during the continuous renal replacement therapy.

Regional Analysis: Anticoagulation Therapy Market
Geographically, anticoagulation therapy market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America anticoagulation therapy market is anticipated to exhibit lucrative growth owing to increase in the prevalence of venous thromboembolism and innovation of newer drugs for anticoagulation therapy. Europe anticoagulation therapy market growing at significant rate owing to rise in prevalence of cardiovascular diseases due to change in lifestyle and high awareness among physicians regarding anticoagulation therapy drugs are bolster the market. Asia Pacific anticoagulation therapy market accounted for notable share, which is attributed to rise in medical tourism, increase in geriatric population, and rise in per capita income in the region. Latin America anticoagulation therapy market is anticipated to grow at significant rate due to adoption of novel oral anticoagulants, expansion of business by market players, and rise in prevalence of atrial fibrillation and coronary artery diseases.

Need more information about this report @
https://www.precisionbusinessinsights.com/market-reports/anticoagulation-therapy-market/#ulp-14mlyhjMGhVjZqa3



Competition Assessment: Anticoagulation Therapy Market
Some of the players in the global anticoagulation therapy market include:
• Bristol-Myers Squibb (U.S.)
• Pfizer, Inc. (U.S.)
• Johnson & Johnson Services Inc. (U.S.)
• Alere, Inc. (U.S.)
• Abbott, Inc. (U.S.)
• F. Hoffmann La. Roche Ltd. (Switzerland)
• Baxter International, Inc. (U.S.)
• Portola Pharmaceuticals, Inc. (U.S.)
• Daiichi Sankyo Company Ltd. (Japan)
• Siemens AG (Germany)
• CoaguSense, Inc. (US)

Notable Market Developments: Anticoagulation Therapy Market
• In June 2017, Portola Pharmaceuticals received FDA approval for Bevyxxa (betrixaban) used in venous thromboembolism in acute ill patients


Key Features of the Report:
• The report provides granular level information about the market size, regional market share, historic market (2012 to 2016) and forecast (2017 to 2023)
• The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
• The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
• The report tracks recent innovations, key developments and startup’s details that are actively working in the market
• The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
• The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/anticoagulation-therapy-market/

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.

Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com

This release was published on openPR.